Vaccitech plc - ADR

NASDAQ:VACC 3:59:56 PM EDT

2.46

+0.07 (+2.93%)

4:10:01 PM EDT: $2.46 0.00 (0.00%)

Market Cap (Intraday)	94.36M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.7 Million
Adjusted EPS	-$0.55

See more estimates

10-Day MA	$2.44
50-Day MA	$2.38
200-Day MA	$2.77

See more pivots

Vaccitech plc - ADR Stock, NASDAQ:VACC

Zeus Building, Rutherford Avenue, Didcot, Oxfordshire OX11 0DF

United Kingdom

Phone: +44.18.6581.8808

Number of Employees: 107

http://www.vaccitech.co.uk

Description

Vaccitech Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.